Expects to Submit Conditional Marketing Approval Application in Europe for Iopofosine I 131 in Refractory (post-BTKi) ...

Total assets ended the third quarter of 2025 at $486 million , up $53 million since year end 2024. Total deposits ended the third quarter of 2025 at $390 million, up $39 million since year end 2024.

SAN MATEO, Calif., Nov. 12, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative ...

CFO’S MESSAGE Calfrac generated Adjusted EBITDA of $48.5 million and net income of $4.3 million from continuing operations ...

There were 64 selling days for both the three months ended September 30, 2025 and 2024. There were 191 and 192 selling days ...

CF Industries Holdings, Inc. (NYSE: CF), a leading global manufacturer of hydrogen and nitrogen products, today announced ...

Encouraging Phase 1 data on ZW191, an antibody-drug conjugate (ADC) targeting folate receptor-⍺ (FR⍺), presented at the AACR-NCI-EORTCConferenceFirst patient dosed in Phase 1 clinical trial of ZW251 ...

Third Quarter 2025 Financial Results Net revenue in the third quarter of 2025 increased 58% to $11.8 million, compared to $7.5 million in the third quarter of 2024. The increase was due to an increase ...

Prime Minister Mark Carney has revealed the second batch of potentially "nation-building" infrastructure projects to be ...

Calfrac Well Services Ltd. ("Calfrac" or "the Company") (TSX: CFW) announces its financial and operating results for the three and nine months ended ...

Accelsius recently secured strategic investment from Johnson Controls and introduced its NeuCool® MR250 system; pipeline of opportunities now exceeds $1 billion AeroFlexx delivered 5th consecutive qua ...

The MarketWatch News Department was not involved in the creation of this content.-- Third quarter revenue increased 15% year-over-year to $44.2 million -- Commercial Cell & Gene T ...